Could you administer your own flu vaccine next year?

AstraZeneca on Tuesday said it submitted an application to FDA that would allow its intranasal flu vaccine to be administered at home by individuals or caregivers instead of healthcare professionals, potentially increasing access to the vaccine.

Your guide to COVID-19, RSV, and flu vaccines this fall

Could a self-administered flu vaccine be on its way?

In 2003, FDA approved AstraZeneca’s FluMist, an intranasal flu vaccine, for individuals ages two to 49 years of age. It is the only intranasal vaccine licensed for human use in the United States.

On Tuesday, AstraZeneca announced it submitted a supplemental biologics license application to...